🇺🇸 FDA
Patent

US 11512113

Cleavable linker compositions and methods

granted A61KA61K47/65A61K47/68

Quick answer

US patent 11512113 (Cleavable linker compositions and methods) held by JANUX THERAPEUTICS, INC. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
JANUX THERAPEUTICS, INC.
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K47/65, A61K47/68, A61K47/6889, A61P